PA
Pondavakkam Arunagirinathan Arunodhayan
About Pondavakkam Arunagirinathan Arunodhayan
Data last updated:
Pondavakkam Arunagirinathan Arunodhayan is an Additional Director at Hubra Pharmaceuticals Private Limited (since 2016), Director at 3G Surgical Industries Private Limited (since 2019) and Director at Mokksha Management Services Private Limited (since 2013). The companies operate in Pharma, Healthcare and Business Services. The 3 current companies with reported revenue have a combined latest revenue of ₹18.20 Cr; the largest is Hubra Pharmaceuticals Private Limited at ₹13.56 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Hubra Pharmaceuticals Private Limited U74900TN2016PTC104726 | Additional Director | 21 Apr 2016 | 2016 | ₹13.56 Cr (FY 2024) | Active |
 3G Surgical Industries Private Limited U74999TN2019PTC126777 | Director | 08 Jan 2019 | 2019 | ₹2.83 Cr (FY 2024) | Active |
 Mokksha Management Services Private Limited U74140TN2013PTC093364 | Director | 17 Oct 2013 | 2013 | ₹1.81 Cr (FY 2024) | Active |
Board colleagues of Pondavakkam Arunagirinathan Arunodhayan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Pondahavakkam Arunodayan Priya | 06686026 | Hubra Pharmaceuticals Private Limited , 3G Surgical Industries Private Limited and 1 more | Director |
| Pondavakkam Vijaya Arunagirinathan | 01933631 | Hubra Pharmaceuticals Private Limited | Director |
| Pondavakkam Ananthakrishnan Karthick | 08323967 | 3G Surgical Industries Private Limited | Director |
| Pondavakkam Ayyappan Kokila | 08323968 | 3G Surgical Industries Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Pondavakkam Arunagirinathan Arunodhayan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pondavakkam Arunagirinathan Arunodhayan
Pondavakkam Arunagirinathan Arunodhayan currently holds 3 directorships: Hubra Pharmaceuticals Private Limited (Additional Director, since 21 Apr 2016, revenue ₹13.56 Cr (FY 2024)); 3G Surgical Industries Private Limited (Director, since 08 Jan 2019, revenue ₹2.83 Cr (FY 2024)); Mokksha Management Services Private Limited (Director, since 17 Oct 2013, revenue ₹1.81 Cr (FY 2024)).
Pondavakkam Arunagirinathan Arunodhayan was first appointed on 17 Oct 2013 as Director at Mokksha Management Services Private Limited. The most recent appointment on record is 08 Jan 2019 at 3G Surgical Industries Private Limited.
The 3 current companies of Pondavakkam Arunagirinathan Arunodhayan that report revenue have a combined latest revenue of ₹18.20 Cr: Hubra Pharmaceuticals Private Limited ₹13.56 Cr (FY 2024); 3G Surgical Industries Private Limited ₹2.83 Cr (FY 2024); Mokksha Management Services Private Limited ₹1.81 Cr (FY 2024).
The current boards of Pondavakkam Arunagirinathan Arunodhayan's companies include Pondahavakkam Arunodayan Priya (Hubra Pharmaceuticals Private Limited), Pondavakkam Vijaya Arunagirinathan (Hubra Pharmaceuticals Private Limited), Pondavakkam Ananthakrishnan Karthick (3G Surgical Industries Private Limited), Pondavakkam Ayyappan Kokila (3G Surgical Industries Private Limited).